Does LETROZOLE\RIBOCICLIB Cause Neoplasm malignant? 25 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 25 reports of Neoplasm malignant have been filed in association with LETROZOLE\RIBOCICLIB. This represents 4.0% of all adverse event reports for LETROZOLE\RIBOCICLIB.
25
Reports of Neoplasm malignant with LETROZOLE\RIBOCICLIB
4.0%
of all LETROZOLE\RIBOCICLIB reports
1
Deaths
3
Hospitalizations
How Dangerous Is Neoplasm malignant From LETROZOLE\RIBOCICLIB?
Of the 25 reports, 1 (4.0%) resulted in death, 3 (12.0%) required hospitalization, and 1 (4.0%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LETROZOLE\RIBOCICLIB. However, 25 reports have been filed with the FAERS database.
What Other Side Effects Does LETROZOLE\RIBOCICLIB Cause?
Fatigue (69)
Death (66)
Nausea (57)
White blood cell count decreased (39)
Diarrhoea (35)
Rash (27)
Alopecia (25)
Malaise (24)
Cough (22)
Disease progression (22)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which LETROZOLE\RIBOCICLIB Alternatives Have Lower Neoplasm malignant Risk?
LETROZOLE\RIBOCICLIB vs LEUCOVORIN
LETROZOLE\RIBOCICLIB vs LEUCOVORIN\LEUCOVORIN
LETROZOLE\RIBOCICLIB vs LEUPROLIDE
LETROZOLE\RIBOCICLIB vs LEVALBUTEROL
LETROZOLE\RIBOCICLIB vs LEVAMISOLE